You are here

Article Text

Article menu
Download PDFPDF
DTB select
Missing information in US accelerated approval drug labels

Abstract

Overview of: Ballreich J, Socal M, Bennett CL, et al. Accelerated approval drug labels often lack information for clinical decision-making. Pharmacotherapy 2023;43:300-4.

  • Health Care Quality, Access, and Evaluation
  • Drug-Related Side Effects and Adverse Reactions

https://doi.org/10.1136/dtb.2023.000047

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Provenance and peer review Commissioned; internally peer reviewed.